David L. Sultzer - Concepedia

Author

David L. Sultzer

VA Greater Los Angeles Healthcare System ORCID

Also Known As

Amanda G. Smith, Brinkhous, KM, D L Sultzer, D Sultzer, D. L. Sultzer, D. Sultzer, D.L. Sultzer, DAVID SULTZER, David L Sultzer, David L. Sultzer

188

Publications

12.8K

Citations

H-Index

Concepts

All Affiliations

VA Greater Los Angeles Healthcare System Neurobehavioral Systems University of California, Los Angeles University of California, Irvine University of Southern California

About

David L. Sultzer is an author at VA Greater Los Angeles Healthcare System specializing in medicine, neurology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	2.2K
2	Social Sciences	15	18	1.3K
3	Health Sciences	5	5	329
4	Cognitive Science	2	2	85
5	Diabetes	1	1	156

David L. Sultzer

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease Lon S. Schneider, Pierre N. Tariot, Karen Dagerman, New England Journal of Medicine	2006	1.2K
Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment Zahinoor Ismail, Eric E. Smith, Yonas E. Geda, Alzheimer s & Dementia	2015	793
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations Zahinoor Ismail, Luis Agüera-Ortíz, Henry Brodaty, Journal of Alzheimer s Disease	2017	519
White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease George Bartzokis, Jeffrey L. Cummings, David L. Sultzer, Archives of Neurology	2003	413
Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease George Bartzokis, David L. Sultzer, Po H. Lu, Neurobiology of Aging Disconnection ”Neurodegenerative DiseasesAlzheimer's DiseaseAgingMedicine	2004	363
Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial David L. Sultzer, Sonia M. Davis, Pierre N. Tariot, American Journal of Psychiatry	2008	315
Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD Cheryl Vigen, Wendy J. Mack, Richard S.E. Keefe, American Journal of Psychiatry	2011	282
In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging George Bartzokis, David L. Sultzer, Jeffrey L. Cummings, Archives of General Psychiatry	2000	232
A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease David L. Sultzer, H S Levin, Michael E. Mahler, American Journal of Psychiatry	1993	206
Positron Emission Tomography Metabolic Correlates of Apathy in Alzheimer Disease Gad A. Marshall, Lorena Monserratt, Dylan G. Harwood, Archives of Neurology	2007	206

Page 1